BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 8154642)

  • 1. Oral contraceptive use and mortality during 12 years of follow-up: the Nurses' Health Study.
    Colditz GA
    Ann Intern Med; 1994 May; 120(10):821-6. PubMed ID: 8154642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study.
    Beral V; Hermon C; Kay C; Hannaford P; Darby S; Reeves G
    BMJ; 1999 Jan; 318(7176):96-100. PubMed ID: 9880284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States.
    Schwingl PJ; Ory HW; Visness CM
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):241-9. PubMed ID: 9914611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality among oral contraceptive users: 20 year follow up of women in a cohort study.
    Vessey MP; Villard-Mackintosh L; McPherson K; Yeates D
    BMJ; 1989 Dec; 299(6714):1487-91. PubMed ID: 2514858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the epidemiology of oral contraceptives and disease.
    Prentice RL; Thomas DB
    Adv Cancer Res; 1987; 49():285-401. PubMed ID: 3314396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives and breast cancer: a cooperative Italian study.
    La Vecchia C; Negri E; Franceschi S; Talamini R; Amadori D; Filiberti R; Conti E; Montella M; Veronesi A; Parazzini F
    Int J Cancer; 1995 Jan; 60(2):163-7. PubMed ID: 7829209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cigarette smoking and the risk of epithelial ovarian cancer.
    Franks AL; Lee NC; Kendrick JS; Rubin GL; Layde PM
    Am J Epidemiol; 1987 Jul; 126(1):112-7. PubMed ID: 3591776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptive agents and breast cancer: a population-based case-control study.
    Rohan TE; McMichael AJ
    Med J Aust; 1988 Nov; 149(10):520-6. PubMed ID: 3185321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Researchers can now investigate long-term effects of OCs on cancer.
    Rubin GL; Peterson HB
    Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata.
    Marshall LM; Spiegelman D; Goldman MB; Manson JE; Colditz GA; Barbieri RL; Stampfer MJ; Hunter DJ
    Fertil Steril; 1998 Sep; 70(3):432-9. PubMed ID: 9757871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptives and breast, endometrial, and ovarian cancers. The Cancer and Steroid Hormone Study Group, Atlanta Georgia.
    Gwinn ML
    J Obstet Gynaecol (Lahore); 1985 Jan; 5 Suppl 2():S83-7. PubMed ID: 12268773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives and breast cancer.
    Brinton LA; Hoover R; Szklo M; Fraumeni JF
    Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety of oral contraceptives: epidemiologic insights from the first 30 years.
    Grimes DA
    Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):1950-4. PubMed ID: 1605284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study.
    Hannaford PC; Kay CR
    Br J Gen Pract; 1998 Oct; 48(435):1657-62. PubMed ID: 10071398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives.
    Chie WC; Li CY; Huang CS; Chang KJ; Yen ML; Lin RS
    Int J Cancer; 1998 Jul; 77(2):219-23. PubMed ID: 9650556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer before age 45 and oral contraceptive use: new findings.
    Miller DR; Rosenberg L; Kaufman DW; Stolley P; Warshauer ME; Shapiro S
    Am J Epidemiol; 1989 Feb; 129(2):269-80. PubMed ID: 2912040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
    Petitti DB; Porterfield D
    Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors.
    McTiernan AM; Weiss NS; Daling JR
    Am J Epidemiol; 1984 Sep; 120(3):423-35. PubMed ID: 6475918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
    Jick H; Jick SS; Gurewich V; Myers MW; Vasilakis C
    Lancet; 1995 Dec; 346(8990):1589-93. PubMed ID: 7500750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.